Ken Morrison is a highly experienced global leader in clinical drug development with a focus on oncology. Currently serving as Global Head Operational Strategy & Planning Oncology at Fortrea since July 2023, Ken has previously held leadership roles at Labcorp and Covance, where responsibilities included overseeing operational strategy, innovative service implementation, and driving global oncology initiatives. With a strong track record in project management from positions at PPD and AstraZeneca, complemented by extensive research experience at the National Institutes of Health and BBSRC, Ken’s educational background includes advanced degrees in pharmacology from Harvard Medical School and the University of Aberdeen, along with diplomas from Harvard University and Boston University in relevant research and regulatory fields.
This person is not in any teams
This person is not in any offices